Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Changes in hippocampal metabolites after effective treatment for fibromyalgia: a case study.

Wood PB, Ledbetter CR, Patterson JC 2nd.

Clin J Pain. 2009 Nov-Dec;25(9):810-4. doi: 10.1097/AJP.0b013e3181af129e.

PMID:
19851163
2.

Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome. A study with single-voxel magnetic resonance spectroscopy.

Emad Y, Ragab Y, Zeinhom F, El-Khouly G, Abou-Zeid A, Rasker JJ.

J Rheumatol. 2008 Jul;35(7):1371-7. Epub 2008 May 15.

PMID:
18484688
3.

Hippocampal metabolite abnormalities in fibromyalgia: correlation with clinical features.

Wood PB, Ledbetter CR, Glabus MF, Broadwell LK, Patterson JC 2nd.

J Pain. 2009 Jan;10(1):47-52. doi: 10.1016/j.jpain.2008.07.003. Epub 2008 Sep 4.

PMID:
18771960
4.

Proton MR spectroscopy in the evaluation of cerebral metabolism in patients with fibromyalgia: comparison with healthy controls and correlation with symptom severity.

Petrou M, Harris RE, Foerster BR, McLean SA, Sen A, Clauw DJ, Sundgren PC.

AJNR Am J Neuroradiol. 2008 May;29(5):913-8. doi: 10.3174/ajnr.A0959. Epub 2008 Mar 13.

5.

Prognostic value of proton magnetic resonance spectroscopic imaging for surgical outcome in patients with intractable temporal lobe epilepsy and bilateral hippocampal atrophy.

Li LM, Cendes F, Antel SB, Andermann F, Serles W, Dubeau F, Olivier A, Arnold DL.

Ann Neurol. 2000 Feb;47(2):195-200.

PMID:
10665490
6.

Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response.

Block W, Träber F, von Widdern O, Metten M, Schild H, Maier W, Zobel A, Jessen F.

Int J Neuropsychopharmacol. 2009 Apr;12(3):415-22. doi: 10.1017/S1461145708009516. Epub 2008 Oct 10.

PMID:
18845018
7.

Reduced N-acetylaspartate in the hippocampus in patients with fibromyalgia: a meta-analysis.

Aoki Y, Inokuchi R, Suwa H.

Psychiatry Res. 2013 Sep 30;213(3):242-8. doi: 10.1016/j.pscychresns.2013.03.008. Epub 2013 Jul 5.

PMID:
23835064
8.

Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study.

Unrath A, Ludolph AC, Kassubek J.

J Neurol. 2007 Aug;254(8):1099-106. Epub 2007 Apr 13.

PMID:
17431700
9.

Hippocampal 1H MRS in first-episode bipolar I patients.

Atmaca M, Yildirim H, Ozdemir H, Poyraz AK, Tezcan E, Ogur E.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1235-9. Epub 2006 May 24.

PMID:
16725248
10.
11.

Single voxel proton magnetic resonance spectroscopy in post-stroke depression.

Glodzik-Sobanska L, Slowik A, McHugh P, Sobiecka B, Kozub J, Rich KE, Urbanik A, Szczudlik A.

Psychiatry Res. 2006 Dec 1;148(2-3):111-20. Epub 2006 Nov 7.

PMID:
17088051
12.

Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.

Vagnozzi R, Signoretti S, Tavazzi B, Floris R, Ludovici A, Marziali S, Tarascio G, Amorini AM, Di Pietro V, Delfini R, Lazzarino G.

Neurosurgery. 2008 Jun;62(6):1286-95; discussion 1295-6. doi: 10.1227/01.neu.0000333300.34189.74.

PMID:
18824995
13.

Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging.

Bertolino A, Frye M, Callicott JH, Mattay VS, Rakow R, Shelton-Repella J, Post R, Weinberger DR.

Biol Psychiatry. 2003 May 15;53(10):906-13.

PMID:
12742678
14.
15.

Proton MR spectroscopy in patients with complex partial seizures: single-voxel spectroscopy versus chemical-shift imaging.

Hsu YY, Chang C, Chang CN, Chu NS, Lim KE, Hsu JC.

AJNR Am J Neuroradiol. 1999 Apr;20(4):643-51.

16.

Cognitive correlates of 1H MRSI-detected hippocampal abnormalities in temporal lobe epilepsy.

Martin RC, Sawrie S, Hugg J, Gilliam F, Faught E, Kuzniecky R.

Neurology. 1999 Dec 10;53(9):2052-8.

PMID:
10599780
17.

Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.

Pohl C, Block W, Karitzky J, Träber F, Schmidt S, Grothe C, Lamerichs R, Schild H, Klockgether T.

Arch Neurol. 2001 May;58(5):729-35.

PMID:
11346367
18.

White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?

Fayed N, Morales H, Modrego PJ, Muñoz-Mingarro J.

Acad Radiol. 2006 Feb;13(2):229-35.

PMID:
16428059
19.

Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.

Appenzeller S, Li LM, Costallat LT, Cendes F.

Brain. 2005 Dec;128(Pt 12):2933-40. Epub 2005 Sep 29.

20.

High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease.

Bartha R, Smith M, Rupsingh R, Rylett J, Wells JL, Borrie MJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):786-93. doi: 10.1016/j.pnpbp.2007.12.011. Epub 2007 Dec 23.

PMID:
18252268
Items per page

Supplemental Content

Write to the Help Desk